Clinical Decision Support Toolkit: Pediatric Rules and Reminders

Pediatric Rules and Reminders

Chlamydia, (OCP on medication list AND Last screen >12 months), Due for Chlamydia screen

Clinician Summary
The US Preventive Services Task Force strongly recommends that clinicians routinely screen all sexually active women aged 25 years and younger, and other asymptomatic women at increased risk for infection, for Chlamydial infection

This reminder prompts clinicians to screen High Risk individuals who have the following recorded indicators within the electronic health record (EHR) system:

· gender is female; and

· age < 26 years old; and

· last record of Chlamydia test >12 months ago; and

· med list includes:

ALESSE

APRI

AVIANE

BREVICON

CAMILA

CYCLESSA

DEMULEN 1/35

DEMULEN 1/50

DESOGEN

ERRIN

ESTROSTEP 21

ESTROSTEP FE

ETHINYL ESTRADIOL/NORETHINDRONE ACETATE

ETHINYL ESTRADIOL/NORETHINDRONE ACETATE/FE

LESSINA

LEVLEN

LEVLITE-21

LEVLITE-28

LEVONORGESTREL INTRAUTERINE SYSTEM

LEVORA 0.15/30

LEVORA 0.15/30-21

LEVORA 0.15/30-28

LO/OVRAL

LOESTRIN 21 1.5/30

LOESTRIN 21 1/20

LOESTRIN FE 1.5/30

LOESTRIN FE 1/20

LO-OVRAL

LOW-OGESTREL (28)

MEDROXYPROGESTERONE

MEDROXYPROGESTERONE INJ

MICROGESTIN FE 1.5/30

MICROGESTIN FE 1/20

MIRCETTE

MIRENA INTRAUTERINE SYSTEM

MODICON

NECON 0.5/35

NECON 0.5/35-21

NECON 1/35

NECON 1/50

NECON 10/11

NORDETTE

NORETHIN 1/35E

NORETHIN 1/50M

NORETHINDRONE ACETATE

NORGESTREL

NORGESTREL 0.5MG/ETHINYL ESTRADIOL 0.05MG

NORINYL 1 + 50

NORINYL 1+35

NORINYL 1+50

NOR-Q-D

NUVARING

ORTHO EVRA

ORTHO MICRONOR

ORTHO TRI-CYCLEN

ORTHO TRI-CYCLEN LO

ORTHO-CEPT

ORTHO-CYCLEN

ORTHO-NOVUM 1/35

ORTHO-NOVUM 1/50

ORTHO-NOVUM 10/11

ORTHO-NOVUM 7/7/7

OVCON-35

OVCON-50

OVRAL (MORNING AFTER PILL)

OVRAL-21

OVRAL-28

PLAN B

PORTIA

SEASONALE

TRI-LEVLEN

TRI-NORINYL

TRIPHASIL

TRIVORA

YASMIN

ZOVIA 1/35

ZOVIA 1/50

References

1. Hollblad-Fadiman K, Goldman SM. American College of Preventive Medicine practice policy statement. Screening for Chlamydia trachomatis. Am J Prev Med 2003 Apr;24(3):287-92

Berg AO. Screening for chlamydial infection. Recommendations and rationale. Am J Prev Med 2001 Apr;20(3 Suppl):90-4

Web Links

1. http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm

2. http://www.cdc.gov/nchstp/dstd/HEDIS.htm

3. http://www.ahrq.gov/clinic/ajpmsuppl/chlarr.htm

Implementation Notes

Rule category	Chlamydia Screening
Rule title	Due for Chlamydia screen
Primary Clinical Area	Pediatrics
Secondary Clinical Area
Risk Group Definition	gender is Female and age < 26 years old and med list includes: ALESSE APRI AVIANE BREVICON CAMILA CYCLESSA DEMULEN 1/35 DEMULEN 1/50 DESOGEN ERRIN ESTROSTEP 21 ESTROSTEP FE ETHINYL ESTRADIOL/NORETHINDRONE ACETATE ETHINYL ESTRADIOL/NORETHINDRONE ACETATE/FE LESSINA LEVLEN LEVLITE-21 LEVLITE-28 LEVONORGESTREL INTRAUTERINE SYSTEM LEVORA 0.15/30 LEVORA 0.15/30-21 LEVORA 0.15/30-28 LO/OVRAL LOESTRIN 21 1.5/30 LOESTRIN 21 1/20 LOESTRIN FE 1.5/30 LOESTRIN FE 1/20 LO-OVRAL LOW-OGESTREL (28) MEDROXYPROGESTERONE MEDROXYPROGESTERONE INJ MICROGESTIN FE 1.5/30 MICROGESTIN FE 1/20 MIRCETTE MIRENA INTRAUTERINE SYSTEM MODICON NECON 0.5/35 NECON 0.5/35-21 NECON 1/35 NECON 1/50 NECON 10/11 NORDETTE NORETHIN 1/35E NORETHIN 1/50M NORETHINDRONE ACETATE NORGESTREL NORGESTREL 0.5MG/ETHINYL ESTRADIOL 0.05MG NORINYL 1 + 50 NORINYL 1+35 NORINYL 1+50 NOR-Q-D NUVARING ORTHO EVRA ORTHO MICRONOR ORTHO TRI-CYCLEN ORTHO TRI-CYCLEN LO ORTHO-CEPT ORTHO-CYCLEN ORTHO-NOVUM 1/35 ORTHO-NOVUM 1/50 ORTHO-NOVUM 10/11 ORTHO-NOVUM 7/7/7 OVCON-35 OVCON-50 OVRAL (MORNING AFTER PILL) OVRAL-21 OVRAL-28 PLAN B PORTIA SEASONALE TRI-LEVLEN TRI-NORINYL TRIPHASIL TRIVORA YASMIN ZOVIA 1/35 ZOVIA 1/50
Details for Risk Group	med list contains OCP
Triggering Condition	last record of Chlamydia test >12 months ago
Details for Triggering	check date of most recent Chlamydia test
Condition	Chlamydia
Displayed Message	Contraceptive is on medication list. If patient is sexually active, screen for Chlamydia.
Coded Responses	Snooze Periods
A: Chlamydia screen done today B: Appointment scheduled C: Patient not sexually active D: Patient refused E: Deferred F: Other	A': 12 months B':12 months C':12 months D':3 months E': 3 months F': 1 month

Disclaimer

These rules and/or reminders were created using national, state and local guidelines, and group consensus regarding best practices. These guidelines, and their interpretation by clinicians at Partners Healthcare System, may not represent the standard of care across all regions or settings, and are not intended to be adopted or applied without independent assessment of their suitability for a particular setting. Moreover, guidelines change over time (for example, the age range for children who should receive influenza vaccinations was recently extended to 59 months). The rules and/or reminders may need the addition or modification of certain items to ensure that they remain consistent with current guidelines. Therefore, the rules and/or reminders included here are intended only as examples or guides for the development of similar rules and/or reminders in other settings. Partners Healthcare System and its affiliates disclaim any and all responsibility or liability associated with the use of the rules and/or reminders displayed here by third parties.